-
Signature
-
/s/ Derek Meisner, Attorney-in-Fact
-
Issuer symbol
-
ABOS
-
Transactions as of
-
17 Aug 2023
-
Net transactions value
-
-$240,814
-
Form type
-
4
-
Filing time
-
18 Aug 2023, 18:31:27 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ABOS |
Common Stock |
Options Exercise |
$28,187 |
+39,149 |
|
$0.7200* |
39,149 |
17 Aug 2023 |
Direct |
|
| transaction |
ABOS |
Common Stock |
Sale |
$253,686 |
-39,149 |
-100% |
$6.48 |
0 |
17 Aug 2023 |
Direct |
F1 |
| transaction |
ABOS |
Common Stock |
Options Exercise |
$3,332 |
+2,800 |
|
$1.19* |
2,800 |
17 Aug 2023 |
Direct |
|
| transaction |
ABOS |
Common Stock |
Sale |
$18,648 |
-2,800 |
-100% |
$6.66 |
0 |
17 Aug 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ABOS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-39,149 |
-100% |
$0.000000* |
0 |
17 Aug 2023 |
Common Stock |
39,149 |
$0.7200 |
Direct |
F2 |
| transaction |
ABOS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-2,800 |
-100% |
$0.000000* |
0 |
17 Aug 2023 |
Common Stock |
2,800 |
$1.19 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: